Finding could have implications for other autoimmune disorders, such as type I diabetes
Scientists from the Gladstone Institutes have discovered a way to prevent the development of multiple sclerosis (MS) in mice. Using a drug that blocks the production of a certain type of immune cell linked to inflammation and autoimmunity, the researchers successfully protected against the onset of MS in an animal model of the disease. The scientists say the next step is to test this strategy using other autoimmune disorders.
“We are very excited about these findings,” says Eric Verdin, MD, a senior investigator at Gladstone and co-senior author on the study. “In light of the significant effect the treatment had on inflammation, the implications of these results will likely extend beyond multiple sclerosis to other types of autoimmune disorders. We are particularly interested in testing this in type I diabetes given the similar pathways involved, and we are already seeing very promising results in preliminary experiments.”
In the immune system, two kinds of T cells strike a delicate balance–T helper cells (Th17) activate the immune system, protecting against infections and cancers, while regulatory T cells (Tregs) suppress the system, keeping it in check. A disparity between these cell types, where there are too many Th17 and not enough Tregs, can lead to a hyperactive immune system, resulting in inflammation, tissue damage, and autoimmune disease.
In the current study, published in the Journal of Experimental Medicine, the researchers discovered that an important regulatory protein, sirtuin 1 (SIRT1), is involved in the production of Th17 cells. By blocking this protein, the scientists can protect against the onset of autoimmunity. SIRT1 also has a negative impact on Treg maturation and maintenance, so inhibiting its expression simultaneously enhances the production of Tregs and suppresses the creation of Th17.
To test this effect on disease, the researchers used a mouse model of MS and treated the animals with a drug that inhibits SIRT1. Typically, MS-model mice experience severe motor problems, eventually leading to paralysis, but when they were given the drug the mice behaved perfectly normally. Moreover, the treated animals showed no signs of inflammation or cell damage in their spines, classic markers for MS.
Read more:Â Gladstone scientists discover potential new treatment for multiple sclerosis
The Latest on: Inflammation and autoimmunity
[google_news title=”” keyword=”Inflammation and autoimmunity” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Inflammation and autoimmunity
- Nutrition expert pinpoints four foods to avoid heart disease, diabetes and autoimmune disorderson May 17, 2024 at 5:28 am
Inflammation is a short-term response that helps fight infections and heal injuries. But when it gets out of hand, it can spark chronic diseases, including heart disease, type 2 diabetes, autoimmune ...
- Nutrition expert says eat these foods to avoid heart disease, diabetes and autoimmune disorderson May 17, 2024 at 1:41 am
Research has shown too much inflammation in the body can trigger various chronic illnesses, such as obesity, type 2 diabetes, and dementia ...
- COVID-19 linked to rise in autoimmune lung disease, study findson May 15, 2024 at 7:21 pm
A study in eBioMedicine identifies shared immunopathology between SARS-CoV-2 infection and MDA5 autoimmunity, highlighting a surge in MDA5+ cases and interstitial lung disease during the COVID-19 ...
- New stromal cell treatment for chronic inflammatory diseases being trialledon May 15, 2024 at 5:00 pm
People with a range of chronic inflammatory diseases are taking part in a new cell therapy clinical trial that one participant said made them feel “miles better”.
- B cells drive responses of other immune cells, and can be modified to prevent Multiple Sclerosis symptomson May 15, 2024 at 5:00 pm
B cells can control responses of myeloid cells through the release of particular cytokines (small proteins that control the growth and activity of cells in the immune system), challenging the ...
- “Untold Stories” Podcast Shares Powerful Tales of Strength and Perseverance Amid Severe Autoimmune Conditionon May 14, 2024 at 9:40 am
People living with severe autoimmune disorders often feel unseen and unheard, either because others don’t understand their struggles or because they often appear “fine” to the outside world, whereas ...
- GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Updateon May 13, 2024 at 6:13 am
Interim data readout of Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) ...
- Master regulator of inflammation found — and it's in the brain stemon May 10, 2024 at 9:25 am
Research in mice suggests that specific neurons within the brain stem act like the dial on a thermostat — fine-tuning inflammation as and when required.
- Gut bacteria metabolite shows promise in fighting inflammatory bowel diseaseon May 6, 2024 at 4:59 pm
Furthermore, they observed that the enon (a functional group) FAs also suppressed prolonged T-cell proliferation and dendritic cell activation, which can lead to inflammation and autoimmune diseases.
via Bing News